• Last patient dosed in SPL026-SSRI drug interaction study with data readout anticipated in Q3 2023 • Potential for an expedited route to an international,
LSD is a potent hallucinogenic substance that has been used for decades to induce psychedelic experiences. Commonly referred to as “acid,” LSD alters perception, thoughts,
WASHINGTON — At a House oversight hearing Thursday, the Biden administration’s top drug policy official emphasized the need to address both mental illness and drug addiction
WASHINGTON — Republicans on Thursday sought to turn around transgender advocates’ arguments that gender-affirming care is a personal health care decision. The LGBTQ+ community has
More than two dozen prominent health policy experts are urging the Biden administration to ensure that patient data collected about a new Alzheimer’s treatment is
WASHINGTON – The Food and Drug Administration says it needs Congress to give it more power to regulate CBD. Two powerful congressional Republicans made clear
The chief executive of the country’s biggest hospital chain said Thursday that labor costs are now lower as a percent of revenue than they were
The handling of Senate Minority Leader Mitch McConnell’s abrupt medical issue this week is raising concerns among medical experts that the event sent a potentially
The Biden administration continued a bipartisan, decades-long effort to ensure that health insurance treats mental illnesses the same as other ailments, with a new set